GPR84

Nov 27, 2019

Liminal BioSciences to Present at Piper Jaffray Healthcare Conference

Nov 18, 2019

Liminal Presents New Preclinical Data on PBI-4050 and its Effect on Angio-Proliferative Pulmonary Arterial Hypertension

Nov 18, 2019

Liminal BioSciences to Present at the Jefferies 2019 London Healthcare Conference

Nov 15, 2019

Liminal BioSciences to Commence Trading Common Shares on NASDAQ

Sep 04, 2019

Prometic Life Sciences to Present at H.C. Wainwright & Co. 21st Annual Global Investment Conference

Aug 05, 2019

Prometic Life Sciences to Present at Canaccord 39th Annual Growth Conference

Jun 14, 2019

Prometic Presents New Data on PBI-4050 and its Mechanism of Action on Kidney Fibrosis at the 56th ERA/EDTA Congress

May 30, 2019

Prometic Life Sciences to Present at Two Upcoming June Investor Conferences

May 22, 2019

Prometic presents new PBI-4050 and Ryplazim(TM) (plasminogen) data on lung fibrosis at the 2019 ATS Conference

May 08, 2019

Prometic reports its 2019 first quarter financial results